Keller and Heckman offers global food and drug services to its clients. Our comprehensive and extensive food and drug practice is one of the largest in the world. We promote, protect, and defend products made by the spectrum of industries regulated by the U.S. Food and Drug Administration (FDA), the European Commission and Member States authorities in the European Union (EU) and similar authorities throughout the world. The products we help get to market include foods, pharmaceuticals, medical devices, veterinary products, dietary supplements, and cosmetics. In addition, we have a very comprehensive practice in the regulation of packaging materials for food, drugs, and cosmetics and other food-contact articles. We represent clients in addressing all issues relating to these products, including the suitability of their composition, inspection of manufacturing facilities, labeling and advertising, recall procedures, quality assurance programs, and appropriate responses to consumer complaints and tampering incidents. We also vigorously defend our clients when threatened by unwarranted action by competitors or regulatory authorities. We also have substantial experience conducting "due diligence" audits of marketed products, labeling, advertising claims, and manufacturing operations, both for the clients' internal control purposes and as part of product line or corporate acquisitions.
More Legal and Business Bylines From Food and Drug Law at Keller and Heckman
- FDA Releases Update of Priority Guidance Topics for Foods Program - (Posted On Friday, June 28, 2024)
- FDA Issues Warning Letter Related to Allergen Labeling Practices - (Posted On Wednesday, June 26, 2024)
- FDA Continues Response to Contaminated Applesauce Pouches - (Posted On Tuesday, June 25, 2024)
- USDA Proposes Revising Section 8e Import Inspection Fee Structure - (Posted On Friday, June 21, 2024)
- FDA Proposes Traceability Exemption for Cottage Cheese - (Posted On Tuesday, June 18, 2024)
- Kroger Faces Civil Lawsuit Over Calorie Claims on Bread Products - (Posted On Thursday, June 13, 2024)
- FDA to Implement Reorganization of Human Foods Program by October 1 - (Posted On Wednesday, June 12, 2024)
- Consumer Reports Finds High Lead Levels in Snacks for Young Children - (Posted On Tuesday, June 11, 2024)
- FDA Shares Findings from Multi-Year Pathogen Study - (Posted On Thursday, June 06, 2024)
- Health Canada Proposes to Remove Authorization for Brominated Vegetable Oil - (Posted On Wednesday, June 05, 2024)
Keller and Heckman’s Food and Drug Law Practice Group is a Go-To Thought Leader for 2021 for its coverage of Food Labeling Class Action Lawsuits and Regulatory news. The group regularly provides interesting, comprehensive news on topics ranging from class-action lawsuits involving Snack Foods lacking real Wasabi and Canned Green Beans inaccurately claiming to be preservative-free, to proposed federal legislation regulating CBD in food products. NLR readers appreciate the group’s efforts to break down lawsuits and pending legislation impacting the nation's food supply.
The National Law Review Recognizes Keller and Heckman’s Food and Drug Law Practice Group as Go-To Thought Leaders for the firm’s contributions on FDA Regulations and guidelines. Keller and Heckman’s expansive FDA coverage included: proposed rules expanding food traceability and record-keeping requirements, new guidance for animal food additives, a final rule concerning gluten-free food labeling, and approval of a new peanut allergy drug. Addressing the COVID-19 crisis, Keller & Heckman provided news about warnings required by the FDA for Purell and other actions about hand sanitizer and additional Coronavirus prevention and cure claims, the FDA’s and OSHA’s employee health and food safety checklist(s) and COVID-19 best practices for retail and restaurants and COVID-19 Guidance to U.S. food exporters. The firm’s most frequent FDA / Food and Drug Law attorney contributors to the NLR include Azim Chowdhury, Sheila A. Millar, Evangelia Pelonis, Natalie Rainer and LieAnn Van-Tull.